Mohs Micrographic Surgery

Treatment for Non-melanoma skin cancer (squamous-cell carcinoma)

Effectiveness
98%
Safety Score
75%
Clinical Trials
4
Participants
150K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
75
DangerousModerateSafe
Treatment Details
Time to Effect
immediate
Treatment Duration
Single procedure
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$3,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
1
Outcome-Based Costs
Cost per Responder
$3,571
Cost per Remission
$3,571
Comparison vs Surgical Excision
Cost Difference
+$1,000/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Mohs Micrographic Surgery Outcomes

for Non-melanoma skin cancer (squamous-cell carcinoma)

Efficacy Outcomes
Overall Effectiveness
+98%
Response Rate
+98%
Remission Rate
+98%
Common Side Effects
Pain
+30%
Swelling/Bruising
+40%
Infection
+3%
Scarring
+100%
Nerve damage (temporary/permanent)
+2%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
3 active trials recruiting for Mohs Micrographic Surgery in Non-melanoma skin cancer (squamous-cell carcinoma)

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT05108090RECRUITINGNA
View Study
94 participants
INTERVENTIONAL
Indianapolis, United States
Started: Oct 25, 2021

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

NCT07241585NOT YET RECRUITINGNA
View Study
54 participants
INTERVENTIONAL
Cleveland, United States
Started: May 1, 2026

Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma

NCT06782399NOT YET RECRUITINGEARLY_PHASE1
View Study
25 participants
INTERVENTIONAL
Started: Jul 1, 2025